33 0

A teenage health crisis led Surbhi Sarna to found a company aimed at detecting ovarian cancer early. Today Boston Scientific is purchasing the startup firm for up to $275 million. Surbhi Sarna was 13 and working on a school assignment in her bedroom when she felt a pain in her side so severe she blacked out. It was a complex ovarian cyst, doctors told her. What they couldn't tell her at first: whether or not it was cancer. (It wasn't.). A quest to detect ovarian cancer for other women led Sarna, 32, to found a company, nVision Medical of San Bruno, Calif., to raise $17 million in venture capital, and to gain approval from the Food and Drug Administration to develop a specialized device for... Full story

16 April